L-beta-Phenyllactoyl-Tyr-OH

L-beta-Phenyllactoyl-Tyr-OH is a tyrosine-derived amino acid derivative in which the phenyl-lactoyl moiety is attached at the β-position relative to the carbonyl, yielding an acylated, stereochemically defined chiral framework that remains compatible with peptide-related transformations. The molecule contains a phenolic side chain on the Tyr residue, a carboxylic acid for downstream coupling or salt formation, and an amide linkage that modulates nucleophilicity and protects the amino functionality from uncontrolled reactions. The β-phenyl-lactoyl group introduces an additional carbonyl and a stereogenic center environment that can influence chemoselective acyl transfer, deprotection behavior, and fragment stability during synthesis. Overall, the functional group pattern supports use as a protected/activated intermediate for assembling peptide analogs and for generating Tyr-containing scaffolds with controlled side-chain chemistry.

1. Peptide Synthesis

L-beta-Phenyllactoyl-Tyr-OH is applied in peptide synthesis workflows where Tyr building blocks require controlled side-chain handling and a defined acylated amino function for coupling chemistry. The carboxylic acid enables C-terminal activation strategies, while the phenolic hydroxyl on the Tyr side chain can be managed through orthogonal protection or selective derivatization prior to coupling. The β-phenyllactoyl amide motif can be used to tune reactivity, supporting sequential assembly of peptide segments and minimizing side reactions from the amino group during fragment condensation. Incorporation of this Tyr-containing intermediate supports construction of peptide fragments and peptidomimetic sequences where stereochemical fidelity and side-chain functional control are required for downstream scaffold generation.

2. Side-Chain Functionalization

L-beta-Phenyllactoyl-Tyr-OH is suitable for side-chain functionalization studies that exploit the Tyr phenolic group as a handle for chemical biology and materials-oriented conjugation. The phenolic hydroxyl can be converted into ether, ester, or carbonate derivatives to introduce solubility, linker functionality, or reactive groups for subsequent coupling steps, while the β-phenyllactoyl amide and carboxylic acid help maintain the integrity of the amino acid backbone during derivatization. The presence of the additional carbonyl-bearing β-phenyllactoyl fragment can also influence chemoselective transformations by moderating basicity and directing reactivity toward targeted functional group sites. Downstream use can include preparing Tyr-based conjugation intermediates for peptide analogs, affinity probes, and functionalized small molecules derived from amino acid chemistry.

3. Chiral Building Block Development

L-beta-Phenyllactoyl-Tyr-OH is employed as a chiral amino acid intermediate for stereocontrolled synthesis of complex fragments containing a Tyr residue. The defined stereochemical environment around the β-phenyllactoyl unit provides a stereogenic context that can be carried through to coupled products, supporting enantioselective design of peptide building blocks and chiral peptidomimetic scaffolds. The combination of an acylated amino linkage with a free carboxylic acid supports stepwise conversion into activated derivatives suitable for fragment coupling while maintaining stereochemical information. The resulting chiral intermediate can be used to generate stereochemically consistent libraries for structure-activity relationship studies and for method development in amino acid derivatization and peptide construction.

4. Chemical Biology Conjugation

L-beta-Phenyllactoyl-Tyr-OH is used in chemical biology and biomolecule modification contexts where Tyr-based linkers and controlled functional groups are required. The phenolic side chain can be transformed into conjugation-ready moieties, while the carboxylic acid supports formation of amide or ester linkages to introduce tethering units for probes, tags, or affinity handles. The β-phenyllactoyl amide framework provides an acylated backbone that can be incorporated into peptide-like constructs, enabling controlled presentation of Tyr functionality within larger molecular architectures. Downstream applications include preparation of Tyr-containing conjugates for studying molecular recognition, enzyme-substrate interactions, and structure-dependent binding in biochemical research.

5. Pharmaceutical Intermediate Preparation

L-beta-Phenyllactoyl-Tyr-OH is applicable to pharmaceutical intermediate preparation where amino acid-derived fragments and peptidomimetic precursors are assembled under process-compatible protection and activation strategies. The free carboxylic acid supports conversion to coupling-ready forms, while the acylated amino functionality helps regulate reactivity during synthetic sequence design and can be aligned with orthogonal deprotection logic for multi-step manufacturing routes. The Tyr phenolic group can be managed through selective protection or derivatization to control chemoselectivity during scale-up synthesis of peptide-like intermediates. The compound can serve as a defined chiral building block for producing downstream drug-discovery scaffolds, including non-natural peptide analogs and structure-focused intermediate sets used in fine chemical synthesis.

1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

4. Myotropic activity of allatostatins in tenebrionid beetles

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum